Cargando…

Sulindac Derivatives That Activate the Peroxisome Proliferator-activated Receptor γ but Lack Cyclooxygenase Inhibition

[Image: see text] A series of novel derivatives of the nonsteroidal anti-inflammatory drug (NSAID) sulindac sulfide were synthesized as potential agonists of the peroxisome proliferator-activated receptor gamma (PPARγ). Nonpolar and aromatic substitutions on the benzylidene ring as well as retention...

Descripción completa

Detalles Bibliográficos
Autores principales:	Felts, Andrew S., Siegel, Brianna S., Young, Shiu M., Moth, Christopher W., Lybrand, Terry P., Dannenberg, Andrew J., Marnett, Lawrence J., Subbaramaiah, Kotha
Formato:	Texto
Lenguaje:	English
Publicado:	American Chemical Society 2008
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2651753/ https://www.ncbi.nlm.nih.gov/pubmed/18665581 http://dx.doi.org/10.1021/jm700969c

Ejemplares similares

Cyclooxygenase-1-Selective Inhibitors Based on the (E)-2′-Des-methyl-sulindac Sulfide Scaffold
por: Liedtke, Andy J., et al.
Publicado: (2012)

Conservative Secondary Shell Substitution In Cyclooxygenase-2 Reduces Inhibition by Indomethacin Amides and Esters via Altered Enzyme Dynamics
por: Konkle, Mary E., et al.
Publicado: (2015)

Clinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor γ in epithelial ovarian tumours
por: Sakamoto, A, et al.
Publicado: (2004)

Oleamide activates peroxisome proliferator-activated receptor gamma (PPARγ) in vitro
por: Alexander, Stephen PH, et al.
Publicado: (2012)

Lack of the effect of lobeglitazone, a peroxisome proliferator-activated receptor-γ agonist, on the pharmacokinetics and pharmacodynamics of warfarin
por: Jung, Jin Ah, et al.
Publicado: (2015)

Novel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in Rats
por: Tinsley, Heather N., et al.
Publicado: (2023)

Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats
por: Madka, Venkateshwar, et al.
Publicado: (2023)

Structural and Chemical Biology of the Interaction of Cyclooxygenase with Substrates and Non-Steroidal Anti-Inflammatory Drugs
por: Rouzer, Carol A., et al.
Publicado: (2020)

Expression of the genes for peroxisome proliferator-activated receptor-γ, cyclooxygenase-2, and proinflammatory cytokines in granulosa cells from women with polycystic ovary syndrome
por: Lee, Joong Yeup, et al.
Publicado: (2017)

Sulindac metabolites inhibit epidermal growth factor receptor activation and expression
por: Pangburn, Heather A, et al.
Publicado: (2005)

Sulindac activates NF-κB signaling in colon cancer cells
por: Mladenova, Dessislava, et al.
Publicado: (2013)

Endocannabinoid Oxygenation by Cyclooxygenases, Lipoxygenases, and Cytochromes P450: Cross-Talk between the Eicosanoid and Endocannabinoid Signaling Pathways
por: Rouzer, Carol A., et al.
Publicado: (2011)

Inhibition of breast cancer cell motility with a non-cyclooxygenase inhibitory derivative of sulindac by suppressing TGFβ/miR-21 signaling
por: Yi, Bin, et al.
Publicado: (2016)

Peroxisome Proliferator-Activated Receptor-γ in Thyroid Autoimmunity
por: Ferrari, Silvia Martina, et al.
Publicado: (2015)

Obese Mice Lacking Inducible Nitric Oxide Synthase Are Sensitized to the Metabolic Actions of Peroxisome Proliferator–Activated Receptor-γ Agonism
por: Dallaire, Patrice, et al.
Publicado: (2008)

Sulindac for stroke treatment: neuroprotective mechanism and therapy
por: Modi, Jigar Pravinchandra, et al.
Publicado: (2014)

Amine Containing Analogs of Sulindac for Cancer Prevention
por: Mathew, Bini, et al.
Publicado: (2018)

Oxazole and thiazole analogs of sulindac for cancer prevention
por: Mathew, Bini, et al.
Publicado: (2018)

[(123)I]-Celecoxib Analogues as SPECT Tracers of Cyclooxygenase-2 in Inflammation
por: Uddin, Md. Jashim, et al.
Publicado: (2010)

Cyclooxygenase-2 inhibition reduces stress-induced affective pathology
por: Gamble-George, Joyonna Carrie, et al.
Publicado: (2016)

Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancer
por: Hossain, Fokhrul, et al.
Publicado: (2023)

Role of Peroxisome Proliferator-Activated Receptor-γ in Vascular Inflammation
por: Ohshima, Kousei, et al.
Publicado: (2012)

Peroxisome Proliferator-Activated Receptor-γ Is Critical to Cardiac Fibrosis
por: Liu, Huang-Jun, et al.
Publicado: (2016)

Role of Peroxisome Proliferator-Activated Receptor γ in Ocular Diseases
por: Zhang, Su, et al.
Publicado: (2015)

Effect of peroxisome proliferator-activated receptor γ on inflammatory markers
por: Khazaei, Majid
Publicado: (2015)

The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis
por: Li, Jingjing, et al.
Publicado: (2021)

Increased hepatic oxidative metabolism distinguishes the action of Peroxisome proliferator-activated receptor δ from Peroxisome proliferator-activated receptor γ in the ob/ob mouse
por: Roberts, Lee D, et al.
Publicado: (2009)

ID1 Is a Functional Marker for Intestinal Stem and Progenitor Cells Required for Normal Response to Injury
por: Zhang, Ning, et al.
Publicado: (2014)

Inhibition of hypoxia-induced cyclooxygenase-2 by Korean Red Ginseng is dependent on peroxisome proliferator-activated receptor gamma
por: Song, Heewon, et al.
Publicado: (2017)

Sulindac plus a phospholipid is effective for polyp reduction and safer than sulindac alone in a mouse model of colorectal cancer development
por: Davis, Jennifer S., et al.
Publicado: (2020)

Antifibrotic effect by activation of peroxisome proliferator-activated receptor–γ in corneal fibroblasts
por: Pan, Hongwei, et al.
Publicado: (2009)

Peroxisome Proliferator-Activated Receptor γ Activity is Required for Appropriate Cardiomyocyte Differentiation
por: Peymani, Maryam, et al.
Publicado: (2016)

Differential preventive activity of sulindac and atorvastatin in Apc(+/Min-FCCC)mice with or without colorectal adenomas
por: Chang, Wen-Chi L, et al.
Publicado: (2018)

Differential cyclooxygenase expression levels and survival associations in type I and type II ovarian tumors
por: Beeghly-Fadiel, Alicia, et al.
Publicado: (2018)

Ginsenoside Rf inhibits cyclooxygenase-2 induction via peroxisome proliferator–activated receptor gamma in A549 cells
por: Song, Heewon, et al.
Publicado: (2019)

Circulating peroxisome proliferator-activated receptor γ is elevated in systemic sclerosis
por: Żółkiewicz, Jakub, et al.
Publicado: (2019)

Study on cow ghee versus soybean oil on 7,12-dimethylbenz(a)-anthracene induced mammary carcinogenesis & expression of cyclooxygenase-2 & peroxisome proliferators activated receptor- γ in rats
por: Rani, Rita, et al.
Publicado: (2011)

Leptin regulation of the p53-HIF1α/PKM2-aromatase axis in breast adipose stromal cells – a novel mechanism for the obesity-breast cancer link
por: Zahid, Heba, et al.
Publicado: (2017)

Activation and Molecular Targets of Peroxisome Proliferator-Activated Receptor-γ Ligands in Lung Cancer
por: Nemenoff, Raphael A., et al.
Publicado: (2008)

Effects of Sulfonylureas on Peroxisome Proliferator-Activated Receptor γ Activity and on Glucose Uptake by Thiazolidinediones
por: Lee, Kyeong Won, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_dbne72pu30ge6g7gic9c3armgn